Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
diagnostics - search results
If you're not happy with the results, please do another search
Dr Craig Titmus – Mathys & Squire
Dr Craig Titmus is a UK & European Patent Attorney and Partner in the Life Sciences Team at Mathys & Squire.
Genomics and public health: A patent attorney’s perspective
Dr Craig Titmus, Partner and UK and European Patent Attorney at intellectual property firm, Mathys & Squire, turns the spotlight on genomics and public health from a patent attorney’s perspective.
It should never have taken COVID-19 for us to value rapid testing
Daniel Berman, Head of Global Health, Nesta Challenges, says that it should not have taken COVID-19 to emphasise the necessity of rapid testing.
Daniel Berman – Nesta Challenges and the Longitude Prize
Daniel Berman is Head of Global Health at Nesta Challenges and leads the Longitude Prize.
The Longitude Prize is a £10 million ($12.5 million) project designed to incentivise the development of a rapid diagnostic test to improve the use of antibiotics. Daniel represents Nesta in international One Health forums designed...
The FUDIPO Project: AI systems in process industries
Here, Erik Dahlquist discusses the FUDIPO Project, touching on how facilities like oil refineries and power plants can use AI systems.
Nigel Hughes – Observational Health Data Analytics, Epidemiology, Janssen
Nigel Hughes has a thirty-five-year career spanning the NHS in the UK (16 years), NGOs and patient organisations (10 years) and within the pharmaceutical industry (17 years).
EHDEN: The need for European Infrastructure and Health Data Space
Nigel Hughes, Scientific Director at Observational Health Data Analytics, discusses EHDEN project in an environment of AI hype, socio-political unrest and healthcare demands.
What is research bringing to asthma and COPD patients in Europe?
According to Maximilian Kunisch and Giuseppe De Carlo from the European Federation of Allergies and Airways Diseases Patients' Associations, respiratory patients in Europe need to set the research priorities for asthma and chronic obstructive pulmonary disease (COPD).
Advancements in Canada’s cancer care require strong government action
Here, Andrea Seale CEO of the Canadian Cancer Society, discusses the recently elected government’s commitments to support Canadians with cancer.
European Commission announces €232 million aid package to tackle COVID-19
In a bid to tackle the recent outbreak of COVID-19 the European Commission has announced a new aid package worth €232 million.
UK cancer funding reaches £700 million for first time
The National Cancer Research Institute (NCRI) released figures today (4 February) showing that NCRI funding has reached £700 million for the first time.
Radical change is required to ensure an antibiotic future
Daniel Berman, Head of Global Health, Nesta Challenges, highlights the need for radical change in how innovation is funded and prioritised to ensure an antibiotic future given AMR is still climbing, even though behaviours are changing.
Dr Theresa Cruz – National Center for Medical Rehabilitation Research at NICHD
Dr Cruz bio: Theresa Hayes Cruz, Ph.D., became acting director of NCMRR in September 2019 and has been with the U.S. National Institutes of Health since 2009.
A history of fusion research and development Part 5
This article is the last one in a 5 part series on the history of fusion research and development by Matteo Barbarino, a Nuclear Plasma Fusion Specialist from the International Atomic Energy Agency (IAEA).
Cancer: Breakthrough technologies allowing leveraging biomarkers for oncology
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides a cancer focus, in particular, she details breakthrough technologies that allow leveraging biomarkers for oncology.
Partnerships are key to biomedical translational success
Jane Kinghorn, Director at UCL Translational Research Office and Anne Lane, CEO at UCL Business Ltd describe the contributing factors to the success of accelerating biomedical therapeutic translation at UCL and their partner hospitals.
Improving the automation of non-polluting transportation with PEM fuel cells
Here we find out how the Giantleap project improves the automation of non-polluting transportation with the lifetime extension of PEM fuel cells.
Giving oncology its power back: A clinical technology revolution is conquering the US from...
However, the majority of clinical standards for diagnosis and treatment in modern oncology are traditionally birthed solely from biological investigations.
The mechanisms that govern skeletal muscle function
In this second interview, Professor Dr Martin Flück reveals how his research aims to shed light on the mechanisms that govern skeletal muscle function in health and disease, with the goal of translating the findings into more effective clinical applications.
Industrial partnership with university leads research on alternative dental filling material
Case study: UCL researchers and dental materials manufacturer collaborate to speed up the development of a new dental filling material for children.
